AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 161 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,129 | +36.1% | 3,348 | 0.0% | 0.00% | – |
| Q2 2023 | $10,379 | +126.3% | 3,348 | +1.5% | 0.00% | – |
| Q1 2023 | $4,587 | -48.7% | 3,300 | -26.5% | 0.00% | – |
| Q4 2022 | $8,933 | -10.7% | 4,489 | -13.0% | 0.00% | – |
| Q3 2022 | $10,000 | -16.7% | 5,158 | +31.5% | 0.00% | – |
| Q2 2022 | $12,000 | -14.3% | 3,921 | +19.3% | 0.00% | – |
| Q1 2022 | $14,000 | -12.5% | 3,288 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -11.1% | 3,288 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $18,000 | +5.9% | 3,288 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $17,000 | +750.0% | 3,288 | +1041.7% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 288 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |